Analysts Have Conflicting Sentiments on These Healthcare Companies: Cigna (CI), Vertex Pharmaceuticals (VRTX) and Arcus Biosciences (RCUS)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Cigna (CI – Research Report), Vertex Pharmaceuticals (VRTX – ...
Cigna’s Recovery Potential Despite Setbacks: A Buy Rating Justified by Strategic Positioning and Growth Prospects
Mizuho Securities analyst Ann Hynes has maintained their bullish stance on CI stock, giving a Buy rating yesterday.Invest with Confidence: ...